K
Katrina Hueniken
Researcher at Princess Margaret Cancer Centre
Publications - 50
Citations - 142
Katrina Hueniken is an academic researcher from Princess Margaret Cancer Centre. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 4, co-authored 28 publications receiving 48 citations. Previous affiliations of Katrina Hueniken include University Health Network & University of Toronto.
Papers
More filters
Journal ArticleDOI
Measuring financial toxicity incurred after treatment of head and neck cancer: Development and validation of the Financial Index of Toxicity questionnaire
Katrina Hueniken,Catriona M. Douglas,Ashok R. Jethwa,Maryam Mirshams,Lawson Eng,Andrew Hope,Douglas B. Chepeha,David P. Goldstein,Jolie Ringash,Aaron R. Hansen,Rosemary Martino,Rosemary Martino,Madeline Li,Geoffrey Liu,Geoffrey Liu,Wei Xu,John R. de Almeida +16 more
TL;DR: The 9-item Financial Index of Toxicity demonstrated internal and test-retest reliability as well as concurrent and construct validity and Prospective testing in patients with HNC who were treated at other facilities is needed to further establish its responsiveness and generalizability.
Journal ArticleDOI
Outcomes of Long-term Interval Rescreening With Low-Dose Computed Tomography for Lung Cancer in Different Risk Cohorts.
Reenika Aggarwal,Reenika Aggarwal,Andrew C L Lam,Andrew C L Lam,Maureen McGregor,Ravi Menezes,Katrina Hueniken,Hannah Tateishi,Hannah Tateishi,Grainne M. O'Kane,Ming-Sound Tsao,Ming-Sound Tsao,Frances A. Shepherd,Wei Xu,Wei Xu,Micheal McInnis,Heidi Schmidt,Geoffrey Liu,John Kavanagh +18 more
TL;DR: There was a significantly higher incidence of LC in the high-risk cohort than in the moderate- risk cohort, and the cut-point between the high and moderate-risk was determined to be greater than or equal to 3.5% of the 6-year baseline risk.
Journal ArticleDOI
Health-related social media use and preferences of adolescent and young adult cancer patients for virtual programming
Reenika Aggarwal,Reenika Aggarwal,Katrina Hueniken,Katrina Hueniken,Lawson Eng,Lawson Eng,Lawson Eng,Shayan Kassirian,Shayan Kassirian,Ilana Geist,Ilana Geist,Karmugi Balaratnam,Karmugi Balaratnam,Mindy Liang,Mindy Liang,Chelsea Paulo,Arielle Geist,Arielle Geist,Pryangka Rao,Laura Mitchell,Alexander Magony,Alexander Magony,Jennifer M. Jones,Jennifer M. Jones,Samir C. Grover,M. Catherine Brown,M. Catherine Brown,Jackie Bender,Jackie Bender,Wei Xu,Wei Xu,Wei Xu,Geoffrey Liu,Abha A. Gupta +33 more
TL;DR: The internet and SM preferences of AYA related to their cancer information seeking behaviors and their preferences for a future resource compared to middle-aged adults (MAA) are described.
Journal ArticleDOI
Internet and social media use in cancer patients: association with distress and perceived benefits and limitations.
Jacqueline L. Bender,Jacqueline L. Bender,Katrina Hueniken,Katrina Hueniken,Lawson Eng,M. Catherine Brown,Shayan Kassirian,Ilana Geist,Karmugi Balaratnam,Mindy Liang,Chelsea Paulo,Arielle Geist,Pryangka Rao,Alexander Magony,Elliot Charles Smith,Wei Xu,Geoffrey Liu,Abha A. Gupta +17 more
TL;DR: Greater internet confidence, higher education and being female were associated with cancer-related internet/SM use, and distressed cancer patients were also more likely to turn to SM.
Journal ArticleDOI
Real-world health utility scores and toxicities to tyrosine kinase inhibitors in epidermal growth factor receptor mutated advanced non-small cell lung cancer.
Shirley Xue Jiang,Shirley Xue Jiang,R. Walton,Katrina Hueniken,Justine Baek,Justine Baek,Alexandra McCartney,Catherine Labbé,Elliot Charles Smith,Elliot Charles Smith,Sze Wah Samuel Chan,Sze Wah Samuel Chan,RuiQi Chen,RuiQi Chen,Catherine Brown,Devalben Patel,Mindy Liang,Lawson Eng,Lawson Eng,Adrian G. Sacher,Adrian G. Sacher,Penelope A. Bradbury,Penelope A. Bradbury,Natasha B. Leighl,Natasha B. Leighl,Frances A. Shepherd,Frances A. Shepherd,Wei Xu,Geoffrey Liu,M. Hurry,Grainne M. O'Kane,Grainne M. O'Kane +31 more
TL;DR: As the treatment landscape in patients with non‐small cell lung cancer (NSCLC) harboring mutations in the epidermal growth factor receptor (EGFRm) continues to evolve, real‐world health utility scores (HUS) become increasingly important for economic analyses.